Richard F. Saylor, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1600 E High St, Pottstown, PA 19464 Phone: 610-327-7209 |
Dr. Edith Del Mar Behr, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 13 Armand Hammer Blvd, Suite 301, Pottstown, PA 19464 Phone: 610-323-1662 Fax: 610-323-4154 |
Xiang Yuan, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 600 Creekside Dr, Ste 611, Pottstown, PA 19464 Phone: 610-850-4470 Fax: 610-705-5698 |
Dr. Neena K Singh, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1597 Medical Dr Fl 2, Pottstown, PA 19464 Phone: 610-327-7770 |
Dr. Scot David Paris, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1329 E High St, Suite 1, Pottstown, PA 19464 Phone: 610-326-8400 Fax: 610-323-8215 |
News Archive
Determining the cause of an ischemic stroke - one caused by an interruption of blood supply - is critical to preventing a second stroke and is a primary focus in the evaluation of stroke patients. But despite that importance, physicians have long lacked a robust and objective means of doing so.
University of Toronto engineers and a pediatric surgeon have joined forces to discover that physical forces like pressure and tension affect the development of limbs in embryos-research that could someday be used to help prevent birth defects.
For statues, stress injuries come from standing in place for hundreds of years.
Legislation passed in Texas this year will, effective September 1, 2009, amend Texas law governing physician alternative practice sites, such as retail-based Convenient Care clinics. SB 532, supported by the Convenient Care Association and the Texas Medical Association, and sponsored by State Senator Dan Patrick (R-Houston) and Representative Garnet Coleman (D-Houston), increases Texans' access to affordable health care while ensuring high standards for quality of care.
Sen. Chuck Grassley's (R-Iowa) request that the Government Accountability Office investigate whether FDA acted appropriately in granting "accelerated approval" to a cancer drug "will have a catastrophic effect on America's ability to develop new drugs," Mark Thornton, a former medical officer in FDA's Office of Oncology Drug Products and president of the Sarcoma Foundation of America, writes in a Wall Street Journal opinion piece.
› Verified 6 days ago